Neil K. R. Sehgal

2papers

2 Papers

AIJan 19
Real-Time Deadlines Reveal Temporal Awareness Failures in LLM Strategic Dialogues

Neil K. R. Sehgal, Sharath Chandra Guntuku, Lyle Ungar

Large Language Models (LLMs) generate text token-by-token in discrete time, yet real-world communication, from therapy sessions to business negotiations, critically depends on continuous time constraints. Current LLM architectures and evaluation protocols rarely test for temporal awareness under real-time deadlines. We use simulated negotiations between paired agents under strict deadlines to investigate how LLMs adjust their behavior in time-sensitive settings. In a control condition, agents know only the global time limit. In a time-aware condition, they receive remaining-time updates at each turn. Deal closure rates are substantially higher (32\% vs. 4\% for GPT-5.1) and offer acceptances are sixfold higher in the time-aware condition than in the control, suggesting LLMs struggle to internally track elapsed time. However, the same LLMs achieve near-perfect deal closure rates ($\geq$95\%) under turn-based limits, revealing the failure is in temporal tracking rather than strategic reasoning. These effects replicate across negotiation scenarios and models, illustrating a systematic lack of LLM time awareness that will constrain LLM deployment in many time-sensitive applications.

6.5SIMar 12
Self-Reported Side Effects of Semaglutide and Tirzepatide in Online Communities

Neil K. R. Sehgal, Jena Shaw Tronieri, Lyle Ungar et al.

Social media can reveal patient experiences with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) that extend beyond clinical trial data. We analyzed 410,198 Reddit posts (May 2019-June 2025) mentioning semaglutide or tirzepatide. A total of 67,008 users self-reported using these medications, and 43.5% described at least one side effect. Gastrointestinal symptoms predominated, including nausea (36.9%), fatigue (16.7%), vomiting (16.3%), constipation (15.3%), and diarrhea (12.6%). Notably, reproductive symptoms (e.g., menstrual irregularities) and temperature-related complaints (e.g., chills, hot flashes) emerged as unrecognized potential effects. These findings highlight patient concerns not well captured in current labeling or trials. Large-scale social media analysis can complement traditional pharmacovigilance by detecting emerging safety signals and expanding understanding of the real-world safety profile of GLP-1 RAs.